July 24, 2024
National Heart, Lung, and Blood Institute (NHLBI)
The purpose of this Notice is to inform the biomedical research community of the availability of forms to request Helium-3 for FY 2025 that is intended for medical research (such as hyperpolarized MRI). Requests are being accepted now through August 15, 2024.
Request forms and further information may be obtained by emailing the NIH Representative for the DoE Inter-Agency Helium-3 Working Group.
Please direct all inquiries regarding this Notice to:
Simhan Danthi, PhD
(NIH Representative for the DoE Inter-Agency Helium-3 Working Group)
Program Director
National Heart, Lung, and Blood Institute (NHLBI)
Division of Cardiovascular Sciences
Telephone: 301-451-5170
Email: ndanthi@mail.nih.gov